Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 41

1.

Immune regulatory effects of high dose vitamin D3 supplementation in a randomized controlled trial in relapsing remitting multiple sclerosis patients receiving IFNβ; the SOLARIUM study.

Muris AH, Smolders J, Rolf L, Thewissen M, Hupperts R, Damoiseaux J; SOLARIUM study group.

J Neuroimmunol. 2016 Nov 15;300:47-56. doi: 10.1016/j.jneuroim.2016.09.018. Epub 2016 Oct 3.

PMID:
27806875
2.

Induction of an altered CD40 signaling complex by an antagonistic human monoclonal antibody to CD40.

Bankert KC, Oxley KL, Smith SM, Graham JP, de Boer M, Thewissen M, Simons PJ, Bishop GA.

J Immunol. 2015 May 1;194(9):4319-27. doi: 10.4049/jimmunol.1402903. Epub 2015 Mar 20.

3.

GM-CSF production by CD4+ T cells in MS patients: regulation by regulatory T cells and vitamin D.

Peelen E, Muris AH, Damoiseaux J, Knippenberg S, Broens K, Smolders J, Cohen Tervaert JW, Hupperts R, Thewissen M.

J Neuroimmunol. 2015 Mar 15;280:36-42. doi: 10.1016/j.jneuroim.2015.02.007. Epub 2015 Feb 26.

PMID:
25773153
4.

Increased inflammasome related gene expression profile in PBMC may facilitate T helper 17 cell induction in multiple sclerosis.

Peelen E, Damoiseaux J, Muris AH, Knippenberg S, Smolders J, Hupperts R, Thewissen M.

Mol Immunol. 2015 Feb;63(2):521-9.

PMID:
25458313
5.

Circulating vitamin D binding protein levels are not associated with relapses or with vitamin D status in multiple sclerosis.

Smolders J, Peelen E, Thewissen M, Menheere P, Damoiseaux J, Hupperts R.

Mult Scler. 2014 Apr;20(4):433-7. doi: 10.1177/1352458513500552. Epub 2013 Aug 19.

PMID:
23959712
6.

Characterization of skin-resident T cells using a crawl-out method and flow cytometry.

Poot J, Thewissen M, Booi D, Nieuwhof C.

Exp Dermatol. 2013 Aug;22(8):554-5. doi: 10.1111/exd.12191.

PMID:
23879816
7.

Interplay of strongly anisotropic metal ions in magnetic blocking of complexes.

Ungur L, Thewissen M, Costes JP, Wernsdorfer W, Chibotaru LF.

Inorg Chem. 2013 Jun 3;52(11):6328-37. doi: 10.1021/ic302568x. Epub 2013 May 21.

PMID:
23692474
8.

Regulatory B cells in ANCA-associated vasculitis.

Wilde B, Thewissen M, Damoiseaux J, Knippenberg S, Hilhorst M, van Paassen P, Witzke O, Cohen Tervaert JW.

Ann Rheum Dis. 2013 Aug;72(8):1416-9. doi: 10.1136/annrheumdis-2012-202986. Epub 2013 May 10.

PMID:
23666929
9.

Fraction of IL-10+ and IL-17+ CD8 T cells is increased in MS patients in remission and during a relapse, but is not influenced by immune modulators.

Peelen E, Thewissen M, Knippenberg S, Smolders J, Muris AH, Menheere P, Tervaert JW, Hupperts R, Damoiseaux J.

J Neuroimmunol. 2013 May 15;258(1-2):77-84. doi: 10.1016/j.jneuroim.2013.02.014. Epub 2013 Mar 19.

10.

Th17 expansion in granulomatosis with polyangiitis (Wegener's): the role of disease activity, immune regulation and therapy.

Wilde B, Thewissen M, Damoiseaux J, Hilhorst M, van Paassen P, Witzke O, Cohen Tervaert JW.

Arthritis Res Ther. 2012 Oct 18;14(5):R227. doi: 10.1186/ar4066.

11.

Intracellular IL-10 detection in T cells by flowcytometry: the use of protein transport inhibitors revisited.

Muris AH, Damoiseaux J, Smolders J, Cohen Tervaert JW, Hupperts R, Thewissen M.

J Immunol Methods. 2012 Jul 31;381(1-2):59-65. doi: 10.1016/j.jim.2012.04.011. Epub 2012 Apr 29.

PMID:
22565155
12.

Th17 expansion in MS patients is counterbalanced by an expanded CD39+ regulatory T cell population during remission but not during relapse.

Peelen E, Damoiseaux J, Smolders J, Knippenberg S, Menheere P, Tervaert JW, Hupperts R, Thewissen M.

J Neuroimmunol. 2011 Dec 15;240-241:97-103. doi: 10.1016/j.jneuroim.2011.09.013. Epub 2011 Oct 26.

13.

Reduction in IL-10 producing B cells (Breg) in multiple sclerosis is accompanied by a reduced naïve/memory Breg ratio during a relapse but not in remission.

Knippenberg S, Peelen E, Smolders J, Thewissen M, Menheere P, Cohen Tervaert JW, Hupperts R, Damoiseaux J.

J Neuroimmunol. 2011 Oct 28;239(1-2):80-6. doi: 10.1016/j.jneuroim.2011.08.019. Epub 2011 Sep 21.

PMID:
21940055
14.

Neutrophils and T cells: bidirectional effects and functional interferences.

Thewissen M, Damoiseaux J, van de Gaar J, Tervaert JW.

Mol Immunol. 2011 Sep;48(15-16):2094-101. doi: 10.1016/j.molimm.2011.07.006. Epub 2011 Aug 2.

PMID:
21813180
15.

Effect of vitamin D(3) supplementation on peripheral B cell differentiation and isotype switching in patients with multiple sclerosis.

Knippenberg S, Smolders J, Thewissen M, Peelen E, Tervaert JW, Hupperts R, Damoiseaux J.

Mult Scler. 2011 Dec;17(12):1418-23. doi: 10.1177/1352458511412655. Epub 2011 Jun 20.

PMID:
21690147
16.

Effects of vitamin D on the peripheral adaptive immune system: a review.

Peelen E, Knippenberg S, Muris AH, Thewissen M, Smolders J, Tervaert JW, Hupperts R, Damoiseaux J.

Autoimmun Rev. 2011 Oct;10(12):733-43. doi: 10.1016/j.autrev.2011.05.002. Epub 2011 May 18. Review.

PMID:
21621002
17.

Vitamin D-related gene expression profiles in immune cells of patients with relapsing remitting multiple sclerosis.

Smolders J, Thewissen M, Theunissen R, Peelen E, Knippenberg S, Menheere P, Cohen Tervaert JW, Hupperts R, Damoiseaux J.

J Neuroimmunol. 2011 Jun;235(1-2):91-7. doi: 10.1016/j.jneuroim.2011.03.012. Epub 2011 Apr 20.

PMID:
21507492
18.

Safety and T cell modulating effects of high dose vitamin D3 supplementation in multiple sclerosis.

Smolders J, Peelen E, Thewissen M, Cohen Tervaert JW, Menheere P, Hupperts R, Damoiseaux J.

PLoS One. 2010 Dec 13;5(12):e15235. doi: 10.1371/journal.pone.0015235.

19.

Control of T cell activation by vitamin D.

Smolders J, Thewissen M, Damoiseaux J.

Nat Immunol. 2011 Jan;12(1):3; author reply 3-4. doi: 10.1038/ni0111-3a. No abstract available.

PMID:
21169995
20.

T cells in ANCA-associated vasculitis: what can we learn from lesional versus circulating T cells?

Wilde B, Thewissen M, Damoiseaux J, van Paassen P, Witzke O, Tervaert JW.

Arthritis Res Ther. 2010;12(1):204. doi: 10.1186/ar2923. Epub 2010 Feb 24. Review.

Supplemental Content

Loading ...
Support Center